de Leval X - Search Results

1

In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators.

Henrotin Y, de Leval X, Mathy-Hartet M, Mouithys-Mickalad A, Deby-Dupont G, Dogné JM, Delarge J, Reginster JY. Henrotin Y, et al. Among authors: de leval x. Inflamm Res. 2001 Aug;50(8):391-9. doi: 10.1007/PL00000261. Inflamm Res. 2001. PMID: 11556519

2

Spectral and crystallographic study of pyridinic analogues of nimesulide: determination of the active form of methanesulfonamides as COX-2 selective inhibitors.

Julémont F, de Leval X, Michaux C, Damas J, Charlier C, Durant F, Pirotte B, Dogné JM. Julémont F, et al. Among authors: de leval x. J Med Chem. 2002 Nov 7;45(23):5182-5. doi: 10.1021/jm020920n. J Med Chem. 2002. PMID: 12408728

3

First and second generations of COX-2 selective inhibitors.

de Leval X, Julémont F, Benoit V, Frederich M, Pirotte B, Dogné JM. de Leval X, et al. Mini Rev Med Chem. 2004 Aug;4(6):597-601. doi: 10.2174/1389557043403693. Mini Rev Med Chem. 2004. PMID: 15279593 Review.

4

Recent development in the field of dual COX / 5-LOX inhibitors.

Julémont F, Dogné JM, Pirotte B, de Leval X. Julémont F, et al. Among authors: de leval x. Mini Rev Med Chem. 2004 Aug;4(6):633-8. doi: 10.2174/1389557043403747. Mini Rev Med Chem. 2004. PMID: 15279597 Review.

5

Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1).

Mouithys-Mickalad A, Deby-Dupont G, Dogne JM, de Leval X, Kohnen S, Navet R, Sluse F, Hoebeke M, Pirotte B, Lamy M. Mouithys-Mickalad A, et al. Among authors: de leval x. Biochem Biophys Res Commun. 2004 Dec 24;325(4):1122-30. doi: 10.1016/j.bbrc.2004.10.155. Biochem Biophys Res Commun. 2004. PMID: 15555544

6

Effects of nimesulide and indometacin on COX-1 and COX-2: a comparative study.

de Leval X, Dogné JM, Neven P, Labasse A, Delarge J, Reginster JY, Henrotin Y. de Leval X, et al. J Pharm Belg. 1999 May-Jun;54(3):89-90. J Pharm Belg. 1999. PMID: 10431478

7

New trends in thromboxane and prostacyclin modulators.

Dogné JM, de Leval X, Delarge J, David JL, Masereel B. Dogné JM, et al. Among authors: de leval x. Curr Med Chem. 2000 Jun;7(6):609-28. doi: 10.2174/0929867003374868. Curr Med Chem. 2000. PMID: 10702629 Review.

8

Recent advances in inducible cyclooxygenase (COX-2) inhibition.

de Leval X, Delarge J, Somers F, de Tullio P, Henrotin Y, Pirotte B, Dogné JM. de Leval X, et al. Among authors: de tullio p. Curr Med Chem. 2000 Oct;7(10):1041-62. doi: 10.2174/0929867003374417. Curr Med Chem. 2000. PMID: 10911017 Review.

9

Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood.

de Leval X, Delarge J, Devel P, Neven P, Michaux C, Masereel B, Pirotte B, David JL, Henrotin Y, Dogne JM. de Leval X, et al. Prostaglandins Leukot Essent Fatty Acids. 2001 Apr-May;64(4-5):211-6. doi: 10.1054/plef.2001.0262. Prostaglandins Leukot Essent Fatty Acids. 2001. PMID: 11418014

10

Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors.

Julémont F, de Leval X, Michaux C, Renard JF, Winum JY, Montero JL, Damas J, Dogné JM, Pirotte B. Julémont F, et al. Among authors: de leval x. J Med Chem. 2004 Dec 30;47(27):6749-59. doi: 10.1021/jm049480l. J Med Chem. 2004. PMID: 15615524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters